apnea has been researched along with Amaurosis in 7 studies
Apnea: A transient absence of spontaneous respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "3%) had been enrolled in the randomized, placebo-controlled Caffeine for Apnea of Prematurity trial between 1999 and 2004." | 9.16 | Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. ( Anderson, PJ; Asztalos, EV; Barrington, KJ; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2012) |
| "Methylxanthine therapy reduces the frequency of apnea and the need for mechanical ventilation." | 8.82 | Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial. ( Schmidt, B, 2005) |
| "3%) had been enrolled in the randomized, placebo-controlled Caffeine for Apnea of Prematurity trial between 1999 and 2004." | 5.16 | Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. ( Anderson, PJ; Asztalos, EV; Barrington, KJ; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2012) |
| "Methylxanthine therapy reduces the frequency of apnea and the need for mechanical ventilation." | 4.82 | Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial. ( Schmidt, B, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selbst, SM | 1 |
| Schmidt, B | 2 |
| Anderson, PJ | 1 |
| Doyle, LW | 1 |
| Dewey, D | 1 |
| Grunau, RE | 1 |
| Asztalos, EV | 1 |
| Davis, PG | 1 |
| Tin, W | 1 |
| Moddemann, D | 1 |
| Solimano, A | 1 |
| Ohlsson, A | 1 |
| Barrington, KJ | 1 |
| Roberts, RS | 1 |
| FOLEY, J | 1 |
| PATERSON, H | 1 |
| Terlecki, S | 1 |
| Baldwin, BA | 1 |
| Bell, FR | 1 |
| Morris, SA | 1 |
| Harbord, MG | 1 |
| DeSousa, AL | 1 |
| Kleiman, MB | 1 |
| Mealey, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants[NCT00182312] | Phase 3 | 2,000 participants (Anticipated) | Interventional | 1999-10-31 | Completed | ||
| Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784] | Phase 1 | 18 participants (Anticipated) | Interventional | 2024-06-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for apnea and Amaurosis
| Article | Year |
|---|---|
Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
Topics: Aging; Apnea; Blindness; Cerebral Palsy; Cognition Disorders; Deafness; Follow-Up Studies; Humans; I | 2005 |
1 trial available for apnea and Amaurosis
| Article | Year |
|---|---|
Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
Topics: Apnea; Blindness; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Child Development; Ch | 2012 |
Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
Topics: Apnea; Blindness; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Child Development; Ch | 2012 |
Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
Topics: Apnea; Blindness; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Child Development; Ch | 2012 |
Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
Topics: Apnea; Blindness; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Child Development; Ch | 2012 |
5 other studies available for apnea and Amaurosis
| Article | Year |
|---|---|
Pediatric emergency medicine: legal briefs.
Topics: Adolescent; Ambulances; Amputation, Surgical; Apnea; Blindness; Brain Damage, Chronic; Child; Child, | 2013 |
Cortical blindness and spastic quadriparesis following apnoea in an asthmatic attack.
Topics: Apnea; Asthma; Blindness; Blindness, Cortical; Humans; Muscle Spasticity; Paralysis; Quadriplegia | 1954 |
Experimental cerebral ischaemia in sheep. Neuropathology and clinical effects.
Topics: Animals; Apnea; Ataxia; Blindness; Carotid Arteries; Cerebral Cortex; Defecation; Eye Movements; Hip | 1967 |
Infant onset subacute necrotizing encephalomyelopathy (Leigh's disease)
Topics: Apnea; Blindness; Female; Humans; Infant; Lactates; Lactic Acid; Leigh Disease; Male; Seizures | 1993 |
Quadriplegia and cortical blindness in Hemophilus influenzae meningitis.
Topics: Apnea; Arm; Blindness; Child, Preschool; Facial Muscles; Female; Follow-Up Studies; Humans; Leg; Men | 1978 |